Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinhua Pharmaceutical is one of China’s largest and oldest chemical pharmaceutical manufacturers, with global leadership in the production and export of antipyretic analgesics such as ibuprofen and aspirin. The company operates FDA-approved facilities with advanced quality systems audited by international regulators. It supplies APIs, finished dosage forms, intermediates, and chemicals to over 300 clients worldwide—including multinational pharma companies—and holds GMP, ISO9001/14001 certifications. Its pipeline focuses on commercialized generics rather than innovative clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinhua Pharmaceutical.